Harriet De Wit to Hallucinogens
This is a "connection" page, showing publications Harriet De Wit has written about Hallucinogens.
Connection Strength
18.744
-
Psychedelics in Medicine: Can Evidence Keep Up With Enthusiasm? Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May; 9(5):460-461.
Score: 0.833
-
MDMA enhances positive affective responses to social feedback. J Psychopharmacol. 2024 03; 38(3):297-304.
Score: 0.818
-
Microdosing Psychedelics: Current Evidence From Controlled Studies. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May; 9(5):500-511.
Score: 0.818
-
Greater subjective effects of a low dose of LSD in participants with depressed mood. Neuropsychopharmacology. 2024 Apr; 49(5):774-781.
Score: 0.810
-
Impaired inhibition after delta-9-tetrahydrocannabinol in women not related to circulating estradiol levels. Pharmacol Biochem Behav. 2023 04; 225:173547.
Score: 0.773
-
Progress and Puzzles in Psychedelic Therapy. Biol Psychiatry. 2023 02 01; 93(3):210.
Score: 0.764
-
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity. Neuropsychopharmacology. 2023 01; 48(2):418-426.
Score: 0.750
-
Psychedelics: Old trips, new destinations in psychopharmacology research. Psychopharmacology (Berl). 2022 Jun; 239(6):1643-1645.
Score: 0.730
-
Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC. Neuropsychopharmacology. 2022 06; 47(7):1331-1338.
Score: 0.713
-
Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women. Psychopharmacology (Berl). 2022 May; 239(5):1487-1497.
Score: 0.713
-
Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study. Addict Biol. 2022 03; 27(2):e13143.
Score: 0.713
-
Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults. Psychopharmacology (Berl). 2022 Jun; 239(6):1735-1747.
Score: 0.697
-
Can MDMA Change Sociopolitical Values? Insights From a Research Participant. Biol Psychiatry. 2021 06 01; 89(11):e61-e62.
Score: 0.673
-
?9-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial. Neuropsychopharmacology. 2020 10; 45(11):1807-1816.
Score: 0.632
-
MDMA enhances pleasantness of affective touch. Neuropsychopharmacology. 2020 01; 45(1):217-239.
Score: 0.600
-
Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers. Biol Psychiatry. 2019 11 15; 86(10):792-800.
Score: 0.593
-
Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation. Psychopharmacology (Berl). 2018 02; 235(2):373-375.
Score: 0.540
-
MDMA Impairs Both the Encoding and Retrieval of Emotional Recollections. Neuropsychopharmacology. 2018 03; 43(4):791-800.
Score: 0.524
-
MDMA does not alter responses to the Trier Social Stress Test in humans. Psychopharmacology (Berl). 2017 Jul; 234(14):2159-2166.
Score: 0.512
-
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? J Psychopharmacol. 2016 12; 30(12):1248-1258.
Score: 0.489
-
Oxytocin receptor gene variation predicts subjective responses to MDMA. Soc Neurosci. 2016 12; 11(6):592-9.
Score: 0.472
-
Intimate insight: MDMA changes how people talk about significant others. J Psychopharmacol. 2015 Jun; 29(6):669-77.
Score: 0.446
-
Prosocial effects of MDMA: A measure of generosity. J Psychopharmacol. 2015 Jun; 29(6):661-8.
Score: 0.441
-
MDMA: a social drug in a social context. Psychopharmacology (Berl). 2015 Mar; 232(6):1155-63.
Score: 0.429
-
MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology (Berl). 2014 Oct; 231(21):4219-29.
Score: 0.415
-
'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. Soc Cogn Affect Neurosci. 2014 Aug; 9(8):1076-81.
Score: 0.414
-
Effects of MDMA and Intranasal oxytocin on social and emotional processing. Neuropsychopharmacology. 2014 Jun; 39(7):1654-63.
Score: 0.409
-
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. J Psychopharmacol. 2012 Oct; 26(10):1289-98.
Score: 0.363
-
Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl). 2009 Nov; 207(1):73-83.
Score: 0.300
-
The 3,4-methylenedioxymethamphetamine enhances early visual processing for salient socio-emotional stimuli. Eur J Neurosci. 2024 Jun; 59(12):3224-3235.
Score: 0.208
-
Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine. Neuropsychopharmacology. 2024 Jun; 49(7):1120-1128.
Score: 0.205
-
Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory. Psychol Rev. 2024 Mar; 131(2):523-562.
Score: 0.203
-
Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology. 2003 Jul; 28(7):1356-65.
Score: 0.194
-
Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis. PLoS One. 2021; 16(10):e0258849.
Score: 0.175
-
Developing a phone-based measure of impairment after acute oral ?9-tetrahydrocannabinol. J Psychopharmacol. 2019 09; 33(9):1160-1169.
Score: 0.150
-
Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol. Pharmacol Biochem Behav. 1998 Feb; 59(2):287-93.
Score: 0.135
-
Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect. J Neural Transm (Vienna). 2012 Jun; 119(6):701-7.
Score: 0.088